Cetera Investment Advisers
GOSS icon

Cetera Investment Advisers’s Gossamer Bio GOSS Stock Holding History

Cetera Investment Advisers’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1K Sell
30,749
-3,500
-10% -$5.5K ﹤0.01% 4695
2025
Q4 		$106K Buy
+34,249
New +$97.7K ﹤0.01% 4387
2025
Q1 		– Sell
-25,036
Closed -$22.6K – 4022
2024
Q4 		$22.6K Buy
25,036
+12,500
+100% +$10.7K ﹤0.01% 3700
2024
Q3 		$12.4K Hold
12,536
– – ﹤0.01% 3662
2024
Q2 		$11.3K Hold
12,536
– – ﹤0.01% 3673
2024
Q1 		$14.8K Buy
12,536
+2,536
+25% +$2.79K ﹤0.01% 3645
2023
Q4 		$9.13K Hold
10,000
– – ﹤0.01% 2210
2023
Q3 		$8.33K Buy
+10,000
New +$11.5K ﹤0.01% 2173

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Cetera Investment Advisers's GOSS Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Gossamer Bio (GOSS) stake by 10% in Q1 2026, selling an estimated $5.5K and leaving 30,749 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4695.

Cetera Investment Advisers first reported a position in GOSS in Q3 2023 and has held it in 8 quarters since. The position peaked at $106K in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Cetera Investment Advisers held 30,749 shares of Gossamer Bio worth $10.1K as of Q1 2026.
  • Cetera Investment Advisers sold 3,500 Gossamer Bio shares in Q1 2026, an estimated $5.5K.
  • Gossamer Bio made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4695 holding.
  • Cetera Investment Advisers first reported a position in Gossamer Bio in Q3 2023 and has held it in 8 quarters since.
  • Cetera Investment Advisers's Gossamer Bio position peaked at $106K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.